Mary Miller, Chief Legal Officer at Acrivon Therapeutics, Inc. (ACRV), sold 185 shares at $2.01 ($372) on 2026-08-18, disclosed to the SEC on 2026-08-20.
Open-market sale of $372 ACRV by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BFLY | SELL | 2022-02-17 | $198K | — | Filing → |